Skip to content

Lipid-lowering drugs more effective than switch to NNRTI in managing lipid elevations

Replacement of protease inhibitor results in improved blood fat levels, but doesn't stop fat loss

HIV-1 and HIV-2 coinfection: viral response to HAART differs

Therapeutic drug monitoring: no effect on treatment success with nevirapine

BHIVA issues draft 2005 treatment guidelines, calls for comments by May 3rd

European warning about tenofovir/ddI, and BMS strengthens caution about use of efavirenz during pregnancy

Benefits of genotypic testing confirmed in French clinic study

Pilot study suggests that Kaletra maintenance therapy safe

'Dear Dr' letter issued about risks of using tenofovir and ddI together